Table 1. MRM transitions and MS/MS parameters used in the validation for each analyte.

Analyte	DPa (V)	Precursor ions (m/z)	CEb (eV)	Product ions (m/z)	CXPc (V)	RTd (min)	Relative intensity
Enrofloxacin	72	360.0	30	342.0	12	3.26	19.78±1.6
	72	360.0	50	286.0	12	3.26	19.78±1.6
Ciprofloxacin	61	332.0	30	314.0	12	3.08	55.55±4.3
	61	332.0	47	231.0	12	3.08	55.55±4.3
Sulfaquinoxaline	50	301.0	23	156.0	12	3.56	34.75±1.8
	50	301.0	40	108.0	12	3.56	34.75±1.8
Oxytetracycline	41	461.3	59	201.1	12	3.13	75.29±9.1
	41	461.0	53	283.2	12	3.13	75.29±9.1

^aDP: declustering potential

^bCE: collision energy

^cCXP: collision cell exit potential

^dRT: retention time